Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
shop dildos - is great for every girl.
Popular Articles

1.02 Billion People Hungry - One Sixth Of Humanity Undernourished - More Than Ever Before
World hunger is projected to reach a historic high in 2009 with 1 020 million people going hungry every day, according to new estimates published by FAO today.
drugs without prescription
Researchers Confirm Link Between HPV And Head And Neck Cancer But Europe-wide Survey Shows Woeful Public Ignorance On Role Of Oral Sex
Human papillomavirus (HPV) is an important causative agent in squamous cell cancers of head and neck (HNSCC) a new meta-analysis presented at the American Society of Clinical Oncology (ASCO) confirms; but a separate European survey at the same meeting reveals the public is woefully ignorant about it and possible ways to avoid it. Lack of public awareness about the possible link between HPV-related head and neck cancer and oral sex with multiple partners presents a case for making vaccinations against HPV more widely available to boys as well as girls before they become sexually active, commented leading expert Professor Jean-Louis Lefebvre of Centre Oscar Lambret, Lille, France.
News of the day
Why Smoking Increases The Risk Of Heart Disease And Strokes
Researchers at Charles Drew University of Medicine and Science in Los Angeles and Western University of Health Sciences in Pomona have discovered a reason why smoking increases the risk of heart disease and strokes.
Cardiovascular

Warning Issued Over Proposed Drug Company Promotion Of Medicines To Public, UK

Drug companies may exploit new rules to promote their products to the public but present it as mere provision of information, according to an editorial published this week in the Drug and Therapeutics Bulletin (DTB). Direct advertising of prescription-only medicines to the public is currently not allowed in the European Union (EU), but this position may be undermined by proposals from the European Commission (EC). The proposals, if agreed, would allow drug companies new opportunities to present the public with information about prescription-only medicine through the internet or yet-to-be-defined "health-related publications." The DTB editorial is concerned about the proposals, which it suggests would permit direct advertising to the public in spite of the EU-wide ban. It is proposed that each EU member state would ensure the companies providing the information were monitored and this could involve self-regulation by the companies. "A key concern about these ideas is the intrinsic difficulty in distinguishing between advertising of prescription-only medicines to the public (which would still be banned) and proactive provision of non-promotional information about such products," says the editorial. The UK medicines regulator, the Medicines and Healthcare products Regulatory Agency, is currently carrying out a public consultation on this issue - due to finish on August 14 - but supports the principle of allowing the pharmaceutical industry to give patients more information about medicines. DTB, however, cites the negative experience in the US with direct to consumer advertising, where "infringements of rules on information provision have tended to be detected far too late and where there have been difficulties in imposing effective penalties." The editorial concludes: "We believe that acceptance of the EC"s proposals would permit public dissemination of promotional information about prescription-only medicines, masquerading as "information provision"." Given the obvious conflict of interests, DTB concludes, it would be naç¯ve to think that the pharmaceutical industry would provide independent and reliable information to allow people to make informed choices about treatment. "How to misinform patients." DTB 2009; doi 10.1136/dtb.2009.07.0027 Drug And Therapeutics Bulletin


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009